Cargando…

Current status of sublingual immunotherapy in the United States

Sublingual immunotherapy (SLIT) use in the United States to date has been limited, despite common use and demonstrated efficacy elsewhere in the world. This is largely in part due to lack of FDA-approved SLIT products, lack of established dosing and administration guidelines, and cost concerns. Seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Elenburg, Shelby, Blaiss, Michael S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194410/
https://www.ncbi.nlm.nih.gov/pubmed/25317235
http://dx.doi.org/10.1186/1939-4551-7-24